Protocol for the proposed multi-national trial has been submitted for EU regulatory approval Company will...
Allows for enrollment of up to 40 subjects in up to 20 centers SAN DIEGO, June...
Acquired assets expected to deliver attractive payback and achieve a production rate of 1,000 barrels of oil...
NEW YORK, June 15, 2020 (GLOBE NEWSWIRE) — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading...
TULSA, OK, June 10, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — RJD Green (OTCPK: RJDG)...
Research Study to Use Data and Samples from NurOwn® Phase 3 Clinical Trial WASHINGTON, June 9,...
Dow Jones Industrial Average futures lost 257 points, or 0.9%. S&P 500 futures lost 0.8%....
Stocks tied to the reopening of the economy led the gains once again in premarket...
Wall Street was already on pace for solid weekly gains. Entering Friday’s session, the Dow...
Dow Jones Industrial Average futures traded just above the flatline after dropping more than 100...
Dow futures gained 218 points, or 0.9%. Futures for the S&P 500 added 0.6%. Nasdaq...
The fully enrolled placebo-controlled Phase 3 trial is evaluating NurOwn® investigational treatment in ALS patients...
Futures on the Dow Jones Industrial Average implied an opening gain of about 200 points....
Denver, Colorado, May 19, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — CBD Global Sciences Inc....
Dow Jones Industrial Average futures implied an opening loss of about 24 points. Dow futures...
